We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. On the regional level, as the Human Development Index ...

Sponsor: Boom Broadcast & Media Relations on behalf of LCFAmerica Lung cancer treatment is undergoing a quiet but meaningful ...

Ellipses Pharma ("Ellipses"), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for ...

As life expectancy increases, 1 in 2 men and 1 in 3 women will develop cancer at least once in their lifetime and die from it. However, over the past 20 years, the pace of anticancer drug development ...

The study, published today in Cancer Cell, generated spatial transcriptomic maps in precancerous and more advanced stages of lung cancer to provide a deeper understanding of early lung cancer ...

May 13 (Reuters) - Britain's GSK (GSK.L), opens new tab and drug developer iTeos Therapeutics (ITOS.O), opens new tab said on Tuesday they have stopped developing an experimental lung cancer drug, ...

Research suggests that a combination of toxin exposure, genetics, and hormones may play a role. Tobacco smoking continues to account for most lung cancer cases and related deaths. Although smoking ...

A joint Korean-American research team has proposed a prevention-focused treatment strategy that targets lung cancer at its ...